GTS Securities’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-37,500
Closed -$8.27M 1797
2024
Q3
$8.27M Buy
37,500
+18,200
+94% +$3.77M 0.02% 594
2024
Q2
$3.79M Sell
19,300
-3,300
-15% -$682K 0.01% 1043
2024
Q1
$4.87M Buy
22,600
+1,200
+6% +$252K 0.01% 876
2023
Q4
$4.51M Sell
21,400
-14,400
-40% -$3.07M 0.01% 1077
2023
Q3
$7.17M Buy
+35,800
New +$7.12M 0.01% 754

Other funds holding CME

GTS Securities's CME Position: Q1 2026 in Review

GTS Securities reduced its CME Group (CME) stake by 49% in Q1 2026, selling an estimated $784K and leaving 2,754 shares worth $813K. The position accounts for 0.03% of the portfolio, ranked #481.

GTS Securities first reported a position in CME in Q2 2023 and has held it in 12 quarters since. The position peaked at $2.92M in Q4 2023. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • GTS Securities held 2,754 shares of CME Group worth $813K as of Q1 2026.
  • GTS Securities sold 2,640 CME Group shares in Q1 2026, an estimated $784K.
  • CME Group made up 0.03% of GTS Securities's portfolio in Q1 2026, its #481 holding.
  • GTS Securities first reported a position in CME Group in Q2 2023 and has held it in 12 quarters since.
  • GTS Securities's CME Group position peaked at $2.92M in Q4 2023.
  • 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.